Press "Enter" to skip to content

AstraZeneca Admits Vaxzevria COVID Vaccine Can Cause Fatal Side Effects

By Carolyn Hendler, JD

AstraZeneca plc, the largest and most profitable pharmaceutical company in the United Kindgdom1 has admitted in court documents that its COVID-19 vaccine, Vaxzevria, which was developed in partnership with the University of Oxford, can cause the blood disorder thrombosis with thrombocytopenia syndrome (TTS) in “very rare cases.” TTS is an immune disorder specifically associated with Vaxzevria and sometimes referred to as VITT (vaccine-induced immune thrombotic thrombocytopenia),2 3 which causes blood clots and low platelet counts that have led to the injury and death of recipients of the vaccine.4 5

The AstraZeneca/Oxford University Vaxzevria COVID vaccine was never approved by the U.S. Food and Drug Administration (FDA) to be distributed in the U.S., although the company did conduct clinical trials in the U.S.

While TTS has been listed as a warning since Vaxzevria was approved for public use by government health officials in the U.K. and other countries, this is the first time that AstraZeneca has admitted in court that the vaccine can cause the very serious and often deadly blood disorder. The pending class action lawsuit alleges that Vaxzevria caused serious injury to and the death of certain individuals.6

The stakes are high for the pharmaceutical giant as 51 cases have been filed in London’s High Court with potentially $125 million in damages on the line.7 There have been 445 confirmed cases of TTS and 81 deaths in the United Kingdom post vaccination.8 AstraZeneca protests that Vaxzevria is not the cause of all these cases of TTS and argues that the condition can occur in people who have not received the vaccine. Spokespersons for the pharmaceutical giant said that the company will rely on expert testimony to determine causation in every single case.9

Read Full Article Here…(

Home | Caravan to Midnight (

Live Stream + Chat (

We Need Your Help to Keep Caravan To Midnight Going,

Please Consider Donating to Help Keep Independent Media Independent

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Breaking News: